Physician profile
Katherine E Robben
NPI 1801158845
$1,538.27
in general payments reported to CMS, 2019-2025
22 companies · $234 in 2025
The $234 reported for 2025 was more than what 78% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $32.35 · 2021: $262 · 2022: $312 · 2023: $163 · 2024: $227 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $623.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $223.88 | 2019-2025 | Doc Band |
| Supernus Pharmaceuticals, INC. | $194.04 | 2021-2025 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $180.72 | 2021-2022 | |
| Corium, LLC | $130.99 | 2021-2024 | Azstarys |
| Merck Sharp & Dohme LLC | $109.42 | 2019-2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Arbor Pharmaceuticals, INC. | $69.66 | 2019 | |
| Glaxosmithkline, LLC. | $69.20 | 2023-2025 | Bexsero, Pediarix, Rotarix |
| Ironshore Pharmaceuticals INC. | $63.31 | 2019 | |
| Pfizer INC. | $60.26 | 2019-2023 | |
| Adlon Therapeutics L.P. | $56.82 | 2019-2021 | |
| Sanofi Pasteur INC. | $55.78 | 2025 | |
| Sobi, INC | $53.99 | 2021-2023 | |
| Kaleo, INC. | $48.83 | 2022-2023 | Auvi-Q |
| Neos Therapeutics, Lp | $42.33 | 2019-2022 | |
| Shire North American Group INC | $31.83 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $30.84 | 2025 | Jornay Pm |
| Tris Pharma INC | $29.65 | 2022 | |
| Biogen, INC. | $28.60 | 2024 | Spinraza |
| Neurelis, INC. | $17.32 | 2022 | |
| Exeltis, USA INC. | $14.94 | 2024 | Slynd |
| Horizon Therapeutics Plc | $14.41 | 2019 | |
| Galderma Laboratories, L.P. | $11.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Robben listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.